Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluating technology for acquisition.

Pat Stanfill Edens1, Donna Weber

  • 1HCA Inc, One Park Plaza II-4W, Nashville, TN 37203, USA. pat.stanfilledens@hcahealthcare.com

The Journal of Oncology Management : the Official Journal of the American College of Oncology Administrators
|June 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.

Journal of the National Comprehensive Cancer Network : JNCCN·2022
Same author

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.

Haematologica·2021
Same author

Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2020
Same author

New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity.

Haematologica·2020
Same author

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.

Journal of the National Comprehensive Cancer Network : JNCCN·2019
Same author

Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström's macroglobulinemia.

Leukemia & lymphoma·2018

Technology significantly impacts cancer care costs and outcomes. Understanding its role is crucial for efficient healthcare spending and strategic technology adoption in oncology.

Area of Science:

  • Oncology
  • Health Economics
  • Medical Technology

Background:

  • Cancer care represents a substantial portion of healthcare expenditure, estimated at 8% to 9% of the total.
  • Technology is integral to modern cancer diagnosis and treatment, significantly influencing healthcare costs.

Purpose of the Study:

  • To analyze the role of technology in cancer care.
  • To understand how technology integration impacts healthcare spending and decision-making.
  • To promote clinical cost efficiency in oncology through better technology management.

Main Methods:

  • Literature review on technology's impact on cancer care costs.
  • Analysis of healthcare spending data related to cancer technology.
  • Framework development for technology selection and utilization in oncology.

Related Experiment Videos

Main Results:

  • Technology is a primary driver of healthcare spending in cancer care.
  • Effective integration and selection of technology can lead to cost efficiencies.
  • Informed decision-making regarding technology acquisition is essential for optimizing resource allocation.

Conclusions:

  • Understanding technology's multifaceted role in cancer care is vital for cost containment.
  • Strategic management of diagnostic and treatment technologies can improve clinical and economic outcomes.
  • Prioritizing technology acquisition based on clinical value and cost-efficiency is recommended for sustainable cancer care.